Improving the therapeutic index of systemic therapy with special emphasis on cisplatin and carboplatin

Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer.

Urology·2001

Clinical strategy for the development of angiogenesis inhibitors.

The oncologist·2000

Clinical research and drug development of antivirals in HIV: an industry perspective.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1995

Phase III trial of irradiation plus chemotherapy for patients with hepatic metastases and hepatoma: experience of the Northern California Oncology Group.

NCI monographs : a publication of the National Cancer Institute·1988

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1987

Calibrated phase II clinical trials in oncology.

Statistics in medicine·1986

Systemic therapy for metastatic nasopharyngeal carcinoma in the immunotherapy era: A critical review.

Cancer treatment reviews·2026

Molecular tumor boards implementation in Europe: a scoping review and thematic analysis of challenges and facilitators.

Cancer treatment reviews·2026

Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment options.

Cancer treatment reviews·2026

"Current approaches and emerging strategies in the treatment of ductal carcinoma in situ and premalignant breast lesions".

Cancer treatment reviews·2026

Reduced oxaliplatin exposure in gastrointestinal cancers: A systematic review and meta-analysis.

Cancer treatment reviews·2026

Optimizing the treatment pathway in post-docetaxel mCRPC: PSMA-RLT vs cabazitaxel.

Cancer treatment reviews·2026

Peri-interventional neutrophil extracellular traps and immune surveillance in hepatocellular carcinoma: mechanisms, biomarkers, and recurrence after liver resection or thermal ablation.

Frontiers in oncology·2026

Enhancing intravesical bladder cancer therapy: from mucoadhesive to targeted drug delivery strategies.

Frontiers in medicine·2026

Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report.

Frontiers in immunology·2026

Lysosome-Bursting Calcium Carbonate Nanoparticles Amplify Immunogenic Cell Death via Synergistic Phototherapy and Calcium Overload for Immune Checkpoint Blockade.

Research (Washington, D.C.)·2026

Bio-based nanophotothermal systems as smart drug delivery platforms for multimodal synergistic cancer therapy-a review.

Frontiers in medical technology·2026

Stable disease after multimodal treatment of SMARCA4-deficient undifferentiated tumor concurrently involving the stomach and mediastinum: a case report.

Frontiers in oncology·2026

Related Experiment Videos

Improving the therapeutic index of systemic therapy with special emphasis on cisplatin and carboplatin

Related Concept Videos

Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer.

Clinical strategy for the development of angiogenesis inhibitors.

Clinical research and drug development of antivirals in HIV: an industry perspective.

Phase III trial of irradiation plus chemotherapy for patients with hepatic metastases and hepatoma: experience of the Northern California Oncology Group.

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial.

Calibrated phase II clinical trials in oncology.

Systemic therapy for metastatic nasopharyngeal carcinoma in the immunotherapy era: A critical review.

Molecular tumor boards implementation in Europe: a scoping review and thematic analysis of challenges and facilitators.

Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment options.

"Current approaches and emerging strategies in the treatment of ductal carcinoma in situ and premalignant breast lesions".

Reduced oxaliplatin exposure in gastrointestinal cancers: A systematic review and meta-analysis.

Optimizing the treatment pathway in post-docetaxel mCRPC: PSMA-RLT vs cabazitaxel.

Peri-interventional neutrophil extracellular traps and immune surveillance in hepatocellular carcinoma: mechanisms, biomarkers, and recurrence after liver resection or thermal ablation.

Enhancing intravesical bladder cancer therapy: from mucoadhesive to targeted drug delivery strategies.

Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report.

Lysosome-Bursting Calcium Carbonate Nanoparticles Amplify Immunogenic Cell Death via Synergistic Phototherapy and Calcium Overload for Immune Checkpoint Blockade.

Bio-based nanophotothermal systems as smart drug delivery platforms for multimodal synergistic cancer therapy-a review.

Stable disease after multimodal treatment of SMARCA4-deficient undifferentiated tumor concurrently involving the stomach and mediastinum: a case report.

Related Experiment Videos

Improving the therapeutic index of systemic therapy with special emphasis on cisplatin and carboplatin

Related Concept Videos

Related Articles